Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PDUFA VI: Pediatrics Group Seeks Earlier And Faster Studies

Executive Summary

American Academy of Pediatrics’ legislative proposals for user fee bill also include eliminating automatic orphan drug exemption from Pediatric Research Equity Act study requirements.


Related Content

Pediatric Study Timelines Could Change Under Senate PDUFA Bill
Bill To Speed ANDA Approvals Gets Cool Reception From Industry, US FDA
Pediatric Drug Development A Priority For US FDA’s New Oncology Center Of Excellence
Pediatric Study Compliance Could Face Scrutiny In PDUFA Renewal
Pediatric Study Requirements For Cancer Have FDA Support, But Pose Industry Challenges





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts